Anzeige
Mehr »
Samstag, 07.06.2025 - Börsentäglich über 12.000 News
Starke Zahlen: EBITDA bei 9 Mio.?€ - Startet jetzt die Neubewertung?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2DNC4 | ISIN: CA4838092084 | Ticker-Symbol: N/A
1-Jahres-Chart
KANE BIOTECH INC Chart 1 Jahr
5-Tage-Chart
KANE BIOTECH INC 5-Tage-Chart

Aktuelle News zur KANE BIOTECH Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
30.05.Kane Biotech reports Q1 results2
30.05.Kane Biotech Inc (2): Kane Biotech loses $1.21-million in Q11
29.05.Kane Biotech Inc.: Kane Biotech Announces First Quarter 2025 Financial Results379WINNIPEG, Manitoba, May 29, 2025 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) ("Kane Biotech", "Kane" or the "Company") today announces its first quarter 2025 financial results. First Quarter...
► Artikel lesen
10.05.Kane Biotech Inc (2): Kane Biotech 12-million-share private placement1
06.05.Kane Biotech Inc (2): Kane Biotech closes $1.2-million financing2
KANE BIOTECH Aktie jetzt für 0€ handeln
05.05.Kane Biotech Inc.: Kane Biotech Announces Closing of Private Placement Offering and Loan with Insiders of the Company76Not for distribution to U.S. news wire services or dissemination in the United States WINNIPEG, Manitoba, May 05, 2025 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the "Company"...
► Artikel lesen
28.04.Kane Biotech Inc.: Kane Biotech Announces Fourth Quarter and Full Year 2024 Financial Results, Narrows Strategic Focus and Makes Leadership Change149WINNIPEG, Manitoba, April 28, 2025 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE; OTCQB:KNBIF) ("Kane Biotech", "Kane" or the "Company") today announced its fourth quarter and full year 2024 financial...
► Artikel lesen
21.04.Kane Biotech Inc (2): Kane Biotech 15,985,000-share private placement1
12.04.Kane Biotech Inc (2): Kane enters new marketing deal with Outside the Box1
12.04.Kane Biotech Inc.: Kane Biotech Announces New Agreement with Outside the Box Capital Inc.2
13.03.Kane Biotech Inc (2): Kane Biotech gets OK to start Miami acne clinical study1
13.03.Kane Biotech To Begin Clinical Trial For DispersinB Acne Cleanser Following IRB Approval1
13.03.Kane Biotech Inc.: Kane Biotech Secures IRB Approval to Launch Innovative DispersinB Acne Trial1
11.03.Kane Biotech Inc (2): Kane enters distribution deal with Best Buy Medical4
11.03.Kane Biotech Inc.: Kane Biotech Announces Canadian Distribution Agreement With Best Buy Medical for revyve Antimicrobial Wound Gel234WINNIPEG, Manitoba, March 11, 2025 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) ("Kane Biotech") announces that it has concluded a three-year distribution agreement with Best Buy...
► Artikel lesen
20.02.Kane Biotech Inc (2): Kane completes $423,500 final closing of placement1
19.02.Kane Biotech Inc.: Kane Biotech Announces Second and Final Closing of Private Placement Offering1
21.01.Kane Biotech Inc (2): Kane Biotech to host webinar Jan. 231
21.01.Kane Biotech Inc.: Kane to Host Investor Webinar - What Kane has in Store for 2025 Including the Acquisition of FB Dermatology1
20.01.Kane Biotech Inc (2): Kane Biotech closes $1.27M first tranche of financing1
Weiter >>
28 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1